Efficacy, Safety and Tolerability of ACZ885 in Patients With Active Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

274

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

October 31, 2009

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Canakinumab

DRUG

Placebo

Trial Locations (17)

12206

The Center for Rheumatology, Albany

14618

AAIR Research Center, Rochester

34684

Arthritis Center, Palm Harbor

Arthritis Research of Florida, Inc., Palm Harbor

35294

University of Alabama at Birmingham, Birmingham

36207

Pinnacle Research Group, Anniston

62704

The Arthritis Center, Springfield

63128

St. Louis Cener for Clinical Research, St Louis

85381

Sun Valley Arthritis Center, Ltd, Peoria

85704

Catalina Pointe Arthritis & Rheumatology Specialists, Tucson

97239

Oregon Health Sciences University, Portland

98405

Tacoma Center for Arthritis Research, Tacoma

Unknown

Novartis, Vienna

Novartis, Vilvoorde

Novartis, Dorval

Novartis, Nuremberg

Novartis, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY